hsa_circ_0005963 downregulation suppresses NSCLC malignant progression by miR-506-3p/SOX9-mediated stemness regulation
Epigenomics · 04.05.2026 · 18 (5) · 565-573
DOI: 10.1080/17501911.2026.2654577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epigenomics, online erschienen am 21.05.2026. Verfasst von Xuechao Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Vascular Interventional Therapy, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, SOX9 Transcription Factor. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology and Vascular Interventional Therapy, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Respiratory and Critical Care Medicine, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
Zitieren
APA
Zhou, X., Yao, Y., & Ding, H. (2026). hsa_circ_0005963 downregulation suppresses NSCLC malignant progression by miR-506-3p/SOX9-mediated stemness regulation. Epigenomics, 18(5), 565-573. https://doi.org/10.1080/17501911.2026.2654577
Vancouver
Zhou X, Yao Y, Ding H. hsa_circ_0005963 downregulation suppresses NSCLC malignant progression by miR-506-3p/SOX9-mediated stemness regulation. Epigenomics. 2026;18(5):565-573. doi:10.1080/17501911.2026.2654577
BibTeX
@article{Zhou2026,
author = {Zhou, Xuechao and Yao, Yu and Ding, Huaiyin},
title = {hsa_circ_0005963 downregulation suppresses NSCLC malignant progression by miR-506-3p/SOX9-mediated stemness regulation},
journal = {Epigenomics},
year = {2026},
volume = {18},
number = {5},
pages = {565--573},
doi = {10.1080/17501911.2026.2654577}
}
EUVIMED